Senior Accounting Manager at Asimov

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

Bachelor’s or Master’s degree in Accounting or Finance
7+ years of progressive experience in accounting/finance
CPA certification (strongly preferred)
Prior experience in life sciences, biotech, or high-growth tools/services (ideal)
Strong technical accounting expertise, including revenue recognition, COGS tracking, accruals, and GAAP compliance
Experience with audits, tax compliance, and working directly with external auditors
Proficiency with general ledger systems, procurement platforms, and financial reporting tools
Demonstrated ability to build scalable accounting processes and internal controls in a high-growth company
Analytical mindset with attention to detail; able to identify variances, trends, and risks early
Excellent communication skills, able to translate accounting into clear business insights

Responsibilities

Ensure timely and accurate recording of revenue, COGS, and expenses across all product lines
Maintain reconciliations, accruals, and closing schedules
Lead preparation for the annual audit and liaise with auditors on technical issues (e.g., revenue recognition, asset classification)
Ensure compliance with tax and regulatory requirements
Monitor spend against budget, provide variance analyses, and maintain rolling forecasts with input from department leads
Recommend and implement scalable general ledger and procurement systems (e.g., Prendio or equivalents) to improve reporting, visibility, and spend control
Produce monthly cash flow reports, identify risks to runway, and flag required actions
Prepare accurate and timely monthly/quarterly financial statements, management reports, and supporting schedules for leadership and investors
Manage scalable payroll systems and processes, ensuring accuracy, timeliness, and compliance across multiple states
Partner with HR to support an expanding and distributed workforce
Oversee all accounts payable and receivable activities
Support budgeting and forecasting
Streamline and implement accounting processes

Skills

Revenue Recognition

Audit Preparation

Budgeting

Forecasting

Variance Analysis

Accounts Payable

Accounts Receivable

Cash Flow Reporting

General Ledger

Procurement Systems

Accruals

Reconciliations

COGS Accounting

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters

2017Year Founded

$199.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.

Integration of The Foundry may lead to potential cultural clashes and operational disruptions.

Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.

The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.

Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.

Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.

Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI

Try Jobo Free